Catalysts of change: Immunotherapy's frontier in oral oncology
Oral cancer, which is a kind of HNSCC, presents considerable experimental difficulties because of its high rates of illness and death, often being identified at late stages. Although there have been improvements in conventional treatments such surgery, radiation, and chemotherapy, the outlook for pa...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-09-01
|
Series: | Oral Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024004473 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|